Clinical Trials in Degenerative Diseases : Table of Contents

Users Online: 222

Article Cited by others

RESEARCH ARTICLE

Wharton’s jelly derived allogeneic mesenchymal stromal cells for treatment of type 1 diabetes: Study protocol for a double-blinded, randomized, parallel, placebo-controlled trial

Carlsson Per-Ola, Svahn Mathias G

Year : 2018| Volume: 3| Issue : 2 | Page no: 32-37

This article has been cited by

1	Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era

	Ammira Al-Shabeeb Akil,Esraa Yassin,Aljazi Al-Maraghi,Elbay Aliyev,Khulod Al-Malki,Khalid A. Fakhro

	Journal of Translational Medicine. 2021; 19(1)

	[Pubmed] [Google Scholar] [DOI]

2	Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges

	Mohamed M. Kamal,Dina H. Kassem

	Frontiers in Cell and Developmental Biology. 2020; 8

	[Pubmed] [Google Scholar] [DOI]

3	Wharton’s Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM

	Dina H. Kassem,Mohamed M. Kamal

	Trends in Endocrinology & Metabolism. 2020;

	[Pubmed] [Google Scholar] [DOI]

4	Strategy for the Generation of Engineered Bone Constructs Based on Umbilical Cord Mesenchymal Stromal Cells Expanded with Human Platelet Lysate

	Ingrid Silva-Cote,Mónica Cruz-Barrera,Mariana Cañas-Arboleda,Luz Correa-Araujo,Leidi Méndez,Joanna Jagielska,Bernardo Camacho,Gustavo Salguero

	Stem Cells International. 2019; 2019: 1

	[Pubmed] [Google Scholar] [DOI]